FDA Inspection 1207569 — Corden Pharma S.P.A.

Corden Pharma S.P.A. — FEI 3002880938

The FDA completed an inspection of Corden Pharma S.P.A. on Dec 2, 2022 in Caponago. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 2, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Caponago (Italy)

Additional details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.